These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 10811305)
41. Antibiotic incorporation in jet-sprayed nanofibrillar biodegradable scaffolds for wound healing. Dzikowski M; Castanié N; Guedon A; Verrier B; Primard C; Sohier J Int J Pharm; 2017 Nov; 532(2):802-812. PubMed ID: 28864389 [TBL] [Abstract][Full Text] [Related]
42. Synthesis of elastic biodegradable polyesters of ethylene glycol and butylene glycol from sebacic acid. Park HS; Seo JA; Lee HY; Kim HW; Wall IB; Gong MS; Knowles JC Acta Biomater; 2012 Aug; 8(8):2911-8. PubMed ID: 22522011 [TBL] [Abstract][Full Text] [Related]
43. Synthesis and Characterization of Ciprofloxacin Pendant Antibacterial Cationic Polymers. Xue Y; Guan Y; Zheng A; Wang H; Xiao H J Biomater Sci Polym Ed; 2012; 23(8):1115-28. PubMed ID: 21639974 [TBL] [Abstract][Full Text] [Related]
45. Development of infection resistant polyurethane biomaterials using textile dyeing technology. Phaneuf MD; Bide MJ; Szycher M; Gale MB; Huang H; Yang JC; LoGerfo FW; Quist WC ASAIO J; 2001; 47(6):634-40. PubMed ID: 11730202 [TBL] [Abstract][Full Text] [Related]
46. Hot melt poly-ε-caprolactone/poloxamine implantable matrices for sustained delivery of ciprofloxacin. Puga AM; Rey-Rico A; Magariños B; Alvarez-Lorenzo C; Concheiro A Acta Biomater; 2012 Apr; 8(4):1507-18. PubMed ID: 22251935 [TBL] [Abstract][Full Text] [Related]
47. In situ formation of antimicrobial silver nanoparticles and the impregnation of hydrophobic polycaprolactone matrix for antimicrobial medical device applications. Tran PA; Hocking DM; O'Connor AJ Mater Sci Eng C Mater Biol Appl; 2015 Feb; 47():63-9. PubMed ID: 25492173 [TBL] [Abstract][Full Text] [Related]
48. Two-month ciprofloxacin implants for multibacterial bone infections. Castro C; Evora C; Baro M; Soriano I; Sánchez E Eur J Pharm Biopharm; 2005 Aug; 60(3):401-6. PubMed ID: 15996581 [TBL] [Abstract][Full Text] [Related]
49. Enhancing blood compatibility of biodegradable polymers by introducing sulfobetaine. Cao J; Chen YW; Wang X; Luo XL J Biomed Mater Res A; 2011 Jun; 97(4):472-9. PubMed ID: 21495169 [TBL] [Abstract][Full Text] [Related]
50. Synthesis and Evaluation of Ciprofloxacin-Nitroxide Conjugates as Anti-Biofilm Agents. Verderosa AD; Mansour SC; de la Fuente-Núñez C; Hancock RE; Fairfull-Smith KE Molecules; 2016 Jun; 21(7):. PubMed ID: 27355936 [TBL] [Abstract][Full Text] [Related]
51. Novel biopolymers as implant matrix for the delivery of ciprofloxacin: biocompatibility, degradation, and in vitro antibiotic release. Fulzele SV; Satturwar PM; Dorle AK J Pharm Sci; 2007 Jan; 96(1):132-44. PubMed ID: 16960824 [TBL] [Abstract][Full Text] [Related]
52. Biodegradable radiopaque iodinated poly(ester urethane)s containing poly(ε-caprolactone) blocks: synthesis, characterization, and biocompatibility. Sang L; Wei Z; Liu K; Wang X; Song K; Wang H; Qi M J Biomed Mater Res A; 2014 Apr; 102(4):1121-30. PubMed ID: 23640806 [TBL] [Abstract][Full Text] [Related]
53. Novel poly-DL-lactide-polycaprolactone copolymer based flexible drug delivery system for sustained release of ciprofloxacin. Waknis V; Jonnalagadda S Drug Deliv; 2011 May; 18(4):236-45. PubMed ID: 21189060 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and characterization of poly-alpha,beta-[N-(2-hydroxyethyl)-L-aspartamide]-g-poly(L-lactide) biodegradable copolymers as drug carriers. Peng T; Cheng SX; Zhuo RX J Biomed Mater Res A; 2006 Jan; 76(1):163-73. PubMed ID: 16258962 [TBL] [Abstract][Full Text] [Related]
57. Synthesis and characterization of polyester conjugates of ciprofloxacin. Sobczak M Eur J Med Chem; 2010 Sep; 45(9):3844-9. PubMed ID: 20541292 [TBL] [Abstract][Full Text] [Related]
58. Development of a biodegradable antibiotic delivery system. Lin SS; Ueng SW; Liu SJ; Chan EC; Chao EK; Tsai CH; Chen KT; Wei FC; Shih CH Clin Orthop Relat Res; 1999 May; (362):240-50. PubMed ID: 10335303 [TBL] [Abstract][Full Text] [Related]
59. Development of ciprofloxacin-loaded nanoparticles: physicochemical study of the drug carrier. Page-Clisson ME; Pinto-Alphandary H; Ourevitch M; Andremont A; Couvreur P J Control Release; 1998 Dec; 56(1-3):23-32. PubMed ID: 9801426 [TBL] [Abstract][Full Text] [Related]
60. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity. Kassab AE; Gedawy EM Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]